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Soil contamination is a major barrier to the redevelopment of many former industrial sites in inner 
cities. High concentrations of contaminants such as lead, cadmium, arsenic, nickel and polycyclic 
aromatic hydrocarbons (PAH) are often found at these “brown sites”. Furthermore, naturally 
occurring high concentrations of elements such as arsenic and cadmium over wide areas may 
restrict the use of land for both residential and recreational purposes.  
 
In the field of human health risk assessment, oral exposure to contaminants is the primary 
pathway of interest, specifically for small children who may ingest considerable amounts of soil 
via hand-to-mouth contact and pica behaviour.  
 
At present, the risks associated with soil ingestion are estimated based upon the total 
contaminant content of soils. However, only a fraction, of the many contaminants in soil, is usually 
taken up into the human body and it appears that risk estimates based on total concentration of 
contaminant result in overestimation of the risk. Many sites across Europe will accordingly be 
falsely classified as contaminated and remediated resulting in excessive costs. A more practical 
approach to this problem requires access to accepted, robust and economically feasible methods 
that can account for the difference between the total and the bioavailable soil contaminant 
concentrations, thereby making risk assessment more accurate but still protective for human 
health.  
 
Bioavailability of soil contaminants is investigated in vivo with experimental animals with the 
associated high costs and ethical concerns. Recently, efforts have therefore been directed 
towards developing and validating in vitro test systems that through simulation of the dissolution 
of soil contaminants in the human gastrointestinal system (the bioaccessibility) can be used to 
estimate the risk associated with oral exposure contaminated soil. As for ecosystem 
bioavailability, reduced human, oral bioavailability and bioaccessibility means reduced toxicity of 
a contaminated soil. 
 
In 1999 research groups across Europe formed the BARGE (BioAccessibility Research Group 
Europe) with the purpose of developing and validating in vitro methods for estimation of soil 
contaminant bioavailability. This special issue on bioaccessibility of soil contaminants describes 
the current state of the art for these in vitro methods. In addition to papers prepared for this 
special issue, it contains a number of full papers that were presented in a special BARGE session 
at the 2005 ConSoil conference in Bordeaux, France. 
 
The editors of the special issue thank all the contributors and reviewers for their efforts and we 
hope that this collection of papers on the issue of soil contaminant bioaccessibility will encourage 
further research in the area as well as application of the principles in practical soil risk 
assessment.  
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